严重耐多药结核病的研究进展

被引：30

作者：

唐神结

肖和平

机构：

[1] 同济大学附属上海市肺科医院结核科上海市结核(肺)重点实验室

来源：

中华结核和呼吸杂志 | 2009年 / 05期

关键词：

D O I：

暂无

中图分类号：

R686 [筋腱、韧带、滑囊疾病及损伤];

学科分类号：

摘要：

<正> 近年来,严重耐对多药结核病(extensively drug resistanttuberculosis,XDR-TB)的流行与传播使本已严峻的全球结核病防治形势变得更为紧迫,引起了各国结核病防治工作者的极大关注。XDR-TB的发生与发展暴露了世界结核病控制措施的薄弱和不足,也给全球公共卫生带来了前所未有的挑战。世界各国结核病防治专家正在寻找XDR-TB产生的

引用

共 10 条

[1]

南非分散式管理耐多药和严重耐多药结核病:一种替代管理模式[J]. N.Padayatchi,G.Friedland,范永德,何广学.国际结核病与肺部疾病杂志(中文版). 2008(04)

[2]

Case Series Report of a Linezolid-Containing Regimen for Extensively Drug-Resistant Tuberculosis*[J] . Rany Condos,Nicos Hadgiangelis,Eric Leibert,Germaine Jacquette,Timothy Harkin,William N. Rom.Chest . 2008 (1)

[3]

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study[J] . Salmaan Keshavjee,Irina Y Gelmanova,Paul E Farmer,Sergey P Mishustin,Aivar K Strelis,Yevgeny G Andreev,Alexander D Pasechnikov,Sidney Atwood,Joia S Mukherjee,Michael L Rich,Jennifer J Furin,Edward A Nardell,Jim Y Kim,Sonya S Shin.The Lancet . 2008 (9647)

[4] Extensively drug-resistant tuberculosis [J].

Madariaga, Miguel G. ;

Lalloo, Umesh G. ;

Swindells, Susan .

AMERICAN JOURNAL OF MEDICINE, 2008, 121 (10) :835-844

[5]

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis : epidemiology and control[J] . Matteelli,Migliori,Cirillo,Centis,Girard,Raviglione.Expert Review of Anti-infective Therapy . 2007 (5)

[6] Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa [J].

Gandhi, Neel R. ;

Moll, Anthony ;

Sturm, A. Willem ;

Pawinski, Robert ;

Govender, Thiloshini ;

Lalloo, Umesh ;

Zeller, Kimberly ;

Andrews, Jason ;

Friedland, Gerald .

LANCET, 2006, 368 (9547) :1575-1580

[7] In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates [J].

Erturan, Z ;

Uzun, M .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (01) :78-80

[8]

Emergence of mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide,2000-2004. Centers for Disease Control and Prevention （CDC）. Morbidity and Mortality Weekly Report . 2006

[9]

Extensively drug-resistant tuberculo- sis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Jeon CY,Hwang SH,Mim JH,Prevots DR,Goldfeder LC,Lee H,Eum SY,Jeon DS,Kang HS,Kim JH,Kim BJ,Kim DY,Holland SM,Park SK,Cho SN,Barry CE,Via LE. Clinical Infectious Diseases . 2008

[10]

Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Kim DH,Kim HJ,Park SK, et al. American Journal of Respiratory and Critical Care Medicine . 2008

← 1 →